Attenuation of Hyperlipidemia by Medicinal Formulations of Emblica officinalis Synergized with Nanotechnological Approaches

Author:

Rachitha Puttasiddaiah1,Krishnaswamy Krupashree2,Lazar Renal Antoinette1,Gupta Vijai Kumar3ORCID,Inbaraj Baskaran Stephen4ORCID,Raghavendra Vinay Basavegowda1,Sharma Minaxi5ORCID,Sridhar Kandi6ORCID

Affiliation:

1. P.G. Department of Biotechnology, Teresian College, Siddarthanagar, Mysuru 570011, India

2. Biochemistry Department, Central Food Technological Research Institute, Mysore 570006, India

3. Biorefining and Advanced Materials Research Center, Scotland’s Rural College (SRUC), Edinburgh EH9 3JG, UK

4. Department of Food Science, Fu Jen Catholic University, New Taipei City 242 05, Taiwan

5. Haute Ecole Provinciale de Hainaut-Condorcet, 7800 Ath, Belgium

6. Department of Food Technology, Koneru Lakshmaiah Education Foundation Deemed to be University, Vaddeswaram 522502, India

Abstract

The ayurvedic herb Emblica officinalis (E. officinalis) is a gift to mankind to acquire a healthy lifestyle. It has great therapeutic and nutritional importance. Emblica officinalis, also known as Indian gooseberry or Amla, is a member of the Euphorbiaceae family. Amla is beneficial for treating illnesses in all its forms. The most crucial component is a fruit, which is also the most common. It is used frequently in Indian medicine as a restorative, diuretic, liver tonic, refrigerant, stomachic, laxative, antipyretic, hair tonic, ulcer preventive, and for the common cold and fever. Hyperlipidemia is also known as high cholesterol or an increase in one or more lipid-containing blood proteins. Various phytocompounds, including polyphenols, vitamins, amino acids, fixed oils, and flavonoids, are present in the various parts of E. officinalis. E. officinalis has been linked to a variety of pharmacological effects in earlier studies, including hepatoprotective, immunomodulatory, antimicrobial, radioprotective, and hyperlipidemic effects. The amla-derived active ingredients and food products nevertheless encounter challenges such as instability and interactions with other food matrices. Considering the issue from this perspective, food component nanoencapsulation is a young and cutting-edge field for controlled and targeted delivery with a range of preventative activities. The nanoformulation of E. officinalis facilitates the release of active components or food ingredients, increased bioaccessibility, enhanced therapeutic activities, and digestion in the human body. Accordingly, the current review provides a summary of the phytoconstituents of E. officinalis, pharmacological actions detailing the plant E. officinalis’s traditional uses, and especially hyperlipidemic activity. Correspondingly, the article describes the uses of nanotechnology in amla therapeutics and functional ingredients.

Publisher

MDPI AG

Reference129 articles.

1. Ezeh, K.J., and Ezeudemba, O. (2021). Hyperlipidemia: A Review of the Novel Methods for the Management of Lipids. Cureus, 13.

2. Natural products for controlling hyperlipidemia: Review;Temraz;Arch. Physiol. Biochem.,2019

3. Therapeutic potential of Phyllanthus emblica (amla): The ayurvedic wonder;Mirunalini;J. Basic Clin. Physiol. Pharmacol.,2010

4. Muzaffar, K., Sofi, S.A., Makroo, H.A., Majid, D., and Dar, B.N. (2022). Insight about the biochemical composition, postharvest processing, therapeutic potential of Indian gooseberry (amla), and its utilization in development of functional foods—A comprehensive review. J. Food Biochem., e14132.

5. Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses and medicinal potentials with respect to molecular mechanisms;Variya;Pharmacol. Res.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3